Corrs is representing Tasmanian Alkaloids in relation to various aspects of its technology for genetically-engineered narcotic (opium) poppies. These are processed to prepare narcotic actives that are used in the manufacture of pharmaceutical products for pain relief. In a novel action, our client is seeking preliminary discovery of documents and records from TPI, based on a belief that it may have a claim of patent infringement against TPI, relating to a possible unauthorised early planting of a seed crop to increase volumes of seed for commercial purposes.